What is the future for surgical oncology?

por Thompson, A M
Publicado 2011

p53-Based cyclotherapy: exploiting the ‘guardian of the genome' to protect normal cells from cytotoxic therapy

por Rao, B, Lain, S, Thompson, A M
Publicado 2013

Transforming growth factor beta 1 is implicated in the failure of tamoxifen therapy in human breast cancer.

por Thompson, A. M., Kerr, D. J., Steel, C. M.
Publicado 1991

The value of high adherence to tamoxifen in women with breast cancer: a community-based cohort study

por McCowan, C, Wang, S, Thompson, A M, Makubate, B, Petrie, D J
Publicado 2013

Aspirin use and survival after the diagnosis of breast cancer: a population-based cohort study

por Fraser, D M, Sullivan, F M, Thompson, A M, McCowan, C
Publicado 2014

Critical determination of the frequency of c-erbB-2 amplification in breast cancer.

por Hubbard, A. L., Doris, C. P., Thompson, A. M., Chetty, U., Anderson, T. J.
Publicado 1994

Cohort study of adherence to adjuvant endocrine therapy, breast cancer recurrence and mortality

por Makubate, B, Donnan, P T, Dewar, J A, Thompson, A M, McCowan, C
Publicado 2013

PS2 mRNA expression adds prognostic information to node status for 6-year survival in breast cancer.

por Thompson, A. M., Elton, R. A., Hawkins, R. A., Chetty, U., Steel, C. M.
Publicado 1998

Reduction in gastric cancer surgical mortality over 10 years: An adverse events analysis

por Young, J.A., Shimi, S.M., Kerr, L., McPhillips, G., Thompson, A.M.
Publicado 2014

Endocranial volume is heritable and is associated with longevity and fitness in a wild mammal

por Logan, C. J., Kruuk, L. E. B., Stanley, R., Thompson, A. M., Clutton-Brock, T. H.
Publicado 2016

Expression of the hypermethylated in cancer gene (HIC-1) is associated with good outcome in human breast cancer

por Nicoll, G, Crichton, D N, McDowell, H E, Kernohan, N, Hupp, T R, Thompson, A M
Publicado 2001

The prolyl 3-hydroxylases P3H2 and P3H3 are novel targets for epigenetic silencing in breast cancer

por Shah, R, Smith, P, Purdie, C, Quinlan, P, Baker, L, Aman, P, Thompson, A M, Crook, T
Publicado 2009

pS2 is an independent factor of good prognosis in primary breast cancer.

por Thompson, A. M., Hawkins, R. A., Elton, R. A., Steel, C. M., Chetty, U., Carter, D. C.
Publicado 1993

Allele loss from 5q21 (APC/MCC) and 18q21 (DCC) and DCC mRNA expression in breast cancer.

por Thompson, A. M., Morris, R. G., Wallace, M., Wyllie, A. H., Steel, C. M., Carter, D. C.
Publicado 1993

Allelic imbalance at chromosome 17p13.3 (YNZ22) in breast cancer is independent of p53 mutation or p53 overexpression and is associated with poor prognosis at medium-term follow-up...

por Thompson, A. M., Crichton, D. N., Elton, R. A., Clay, M. F., Chetty, U., Steel, C. M.
Publicado 1998

Differential p53 protein expression in breast cancer fine needle aspirates: the potential for in vivo monitoring

por Ball, H M-L, Hupp, T R, Ziyaie, D, Purdie, C A, Kernohan, N M, Thompson, A M
Publicado 2001

Cohort study examining tamoxifen adherence and its relationship to mortality in women with breast cancer

por McCowan, C, Shearer, J, Donnan, P T, Dewar, J A, Crilly, M, Thompson, A M, Fahey, T P
Publicado 2008

Progesterone receptor expression is an independent prognostic variable in early breast cancer: a population-based study

por Purdie, C A, Quinlan, P, Jordan, L B, Ashfield, A, Ogston, S, Dewar, J A, Thompson, A M
Publicado 2014

Lack of correlation of stem cell markers in breast cancer stem cells

por Liu, Y, Nenutil, R, Appleyard, M V, Murray, K, Boylan, M, Thompson, A M, Coates, P J
Publicado 2014

Expression of transforming growth factor beta mRNA isoforms in human breast cancer.

por MacCallum, J., Bartlett, J. M., Thompson, A. M., Keen, J. C., Dixon, J. M., Miller, W. R.
Publicado 1994